Promomed reported for 2025 under RAS

Promomed's net profit under RAS for 2025 amounted to ₽123.5 million, compared to a loss of ₽69.4 million in the previous year. Holding company did not receive any income from its subsidiaries in 2025. Figure was ₽249.9 million a year earlier.